The heart failure specialists of tomorrow: a network for young cardiovascular scientists and clinicians.

Heart failure Heart failure specialists of tomorrow Network

Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
06 2020
Historique:
received: 20 02 2020
pubmed: 1 5 2020
medline: 22 6 2021
entrez: 1 5 2020
Statut: ppublish

Résumé

The "Heart failure specialists of Tomorrow" (HoT) group gathers young researchers, physicians, basic scientists, nurses and many other professions under the auspices of the Heart Failure Association of the European Society of Cardiology. After its foundation in 2014, it has quickly grown to a large group of currently 925 members. Membership in this growing community offers many advantages during, before, and after the 'Heart Failure and World Congress on Acute Heart Failure'. These include: eligibility to receive travel grants, participation in moderated poster sessions and young researcher and clinical case sessions, the HoT walk, the career café, access to the networking opportunities, and interaction with a large and cohesive international community that constantly seeks multinational collaborations.

Identifiants

pubmed: 32352242
doi: 10.1002/ehf2.12674
pmc: PMC7261537
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

873-877

Informations de copyright

© 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

Références

Card Fail Rev. 2017 Apr;3(1):7-11
pubmed: 28785469
Eur J Heart Fail. 2014 Feb;16(2):151-62
pubmed: 24464608
J Card Fail. 2019 Feb;25(2):78-86
pubmed: 30423457
Eur J Heart Fail. 2018 Sep;20(9):1338-1347
pubmed: 29952090
Heart Fail Clin. 2019 Jan;15(1):19-27
pubmed: 30449377
Eur J Heart Fail. 2018 Dec;20(12):1615-1633
pubmed: 30411833
ESC Heart Fail. 2018 Apr;5(2):222-232
pubmed: 29235244
ESC Heart Fail. 2020 Jun;7(3):873-877
pubmed: 32352242
Eur J Heart Fail. 2019 Oct;21(10):1169-1186
pubmed: 31129923
Eur J Heart Fail. 2018 Aug;20(8):1169-1174
pubmed: 29791084
ESC Heart Fail. 2018 Jun;5(3):211-217
pubmed: 29457878
ESC Heart Fail. 2018 Feb;5(1):3-8
pubmed: 29160621
ESC Heart Fail. 2018 Dec;5(6):1108-1117
pubmed: 29984916

Auteurs

Markus S Anker (MS)

Division of Cardiology and Metabolism, Department of Cardiology (CVK), Charité, Berlin, Germany.
Department of Cardiology (CBF), Charité, Berlin, Germany.
Berlin Institute of Health Center for Regenerative Therapies (BCRT), Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.

Claire Bouleti (C)

University of Poitiers, Clinical Investigation Center (CIC) INSERM 1402, Cardiology Department, Poitiers University Hospital, Poitiers, France.

Theodoros Christodoulides (T)

CardioHealth Center, Nicosia, Cyprus.

Angela Durante (A)

Biomedicine and Prevention Department, University of Rome "Tor Vergata", Rome, Italy.

Edit Gara (E)

Heart and Vascular Center, Semmelweis University, Budapest, Hungary.

Sara Hadzibegovic (S)

Division of Cardiology and Metabolism, Department of Cardiology (CVK), Charité, Berlin, Germany.
Department of Cardiology (CBF), Charité, Berlin, Germany.
Berlin Institute of Health Center for Regenerative Therapies (BCRT), Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.

Kalliopi Keramida (K)

Medical School, University of Cyprus, Nicosia, Cyprus.
Cardio-oncology clinic, Heart Failure Unit, Department of Cardiology, University Hospital Attikon, Athens, Greece.

Alessia Lena (A)

Division of Cardiology and Metabolism, Department of Cardiology (CVK), Charité, Berlin, Germany.
Department of Cardiology (CBF), Charité, Berlin, Germany.
Berlin Institute of Health Center for Regenerative Therapies (BCRT), Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.

Angela Massouh (A)

School of Nursing, American University of Beirut, Beirut, Lebanon.

Ivan Milinkovic (I)

Clinical Center of Serbia, Belgrade University Faculty of Medicine, Belgrade, Serbia.

Matthias P Nägele (MP)

Cardiology, University Hospital Zurich, Zurich, Switzerland.

Alexander Nossikoff (A)

City Clinic Mladost, Sofia, Bulgaria.

Rui Plácido (R)

Cardiology Department, Santa Maria University Hospital (CHLN), Lisbon Academic Medical Centre, and Centro Cardiovascular da Universidade de Lisboa, Faculdade de Medicina, Lisbon, Portugal.

Tamás Radovits (T)

Heart and Vascular Center, Semmelweis University, Budapest, Hungary.

Heli Tolppanen (H)

Heart and Lung Center, Division of Cardiology, Helsinki University and Helsinki University Hospital, Helsinki, Finland.

Giuseppe Vergaro (G)

Division of Cardiology and Cardiovascular Medicine, Fondazione Toscana Gabriele Monasterio, Pisa, Italy & Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.

Markus Wallner (M)

Lewis Katz School of Medicine, Temple University, Cardiovascular Research Center, Philadelphia, PA, USA.
Division of Cardiology, Medical University of Graz, Graz, Austria.
Center for Biomarker Research in Medicine, CBmed GmbH, Graz, Austria.

Sophie Welch (S)

National Heart and Lung Institute, Imperial College London, London, UK.

Yuri Lopatin (Y)

Volgograd Regional Cardiology Centre, Volgograd State Medical University, Volgograd, Russia.

Mitja Lainscak (M)

Faculty of Medicine, University of Ljubljana and Department of Internal Medicine, General Hospital Murska Sobota, Slovenia.

Alexandre Mebazaa (A)

Department of Anesthesiology and Critical Care Medicine, AP-HP, Saint Louis Lariboisière University Hospitals, Université de Paris, Paris, France.

Andrew J S Coats (AJS)

IRCCS, San Raffaele Pisana, Rome, Italy.

Petar M Seferović (PM)

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Serbian Academy of Sciences and Arts, Belgrade, Serbia.

Ewa A Jankowska (EA)

Centre for Heart Diseases, University Hospital, Wroclaw, and Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH